Old Web
English
Sign In
Acemap
>
Paper
>
Efficacy and Safety of the Melanocortin Agonist PL9643 in a Phase 2 Study of Subjects With Dry Eye Disease
Efficacy and Safety of the Melanocortin Agonist PL9643 in a Phase 2 Study of Subjects With Dry Eye Disease
2021
Kenneth R. Kenyon
George W. Ousler
Michael Watson
Gail Torkildsen
Patrick Vollmer
Eugene B. McLaurin
David M. Evans
Jason Winters
John Dodd
Robert Jordan
Stephen Wills
Carl Spana
Keywords:
Disease
Medicine
Endocrinology
Internal medicine
Phases of clinical research
Melanocortin agonist
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]